Chronic Therapy for Congestive Heart Failure with Benazepril HCl, a New Angiotensin Converting Enzyme Inhibitor
- 31 December 1990
- journal article
- clinical trial
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 300 (6) , 354-360
- https://doi.org/10.1097/00000441-199012000-00003
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Pharmacokinetics of a new angiotensin-converting enzyme inhibitor, benazepril hydrochloride, in special populationsAmerican Heart Journal, 1989
- Definition of the effective dose of the converting-enzyme inhibitor benazeprilAmerican Heart Journal, 1989
- ACE inhibition for the failing heart: Experience with captoprilAmerican Heart Journal, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failureAmerican Heart Journal, 1982
- Angiotensin-converting enzyme inhibition and prostaglandinsThe American Journal of Cardiology, 1982
- Reduction of plasma and urinary vasopressin during treatment of severe hypertension by captoprilEuropean Journal of Clinical Investigation, 1981
- Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1980
- Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure.Circulation, 1978
- Hormones and the Pathogenesis of Congestive Heart Failure:Vasopressin, Aldosterone, and Angiotensin IICirculation, 1962